Early declines on Friday were largely negated closer to midday as investors understood the move to raise discount rates to signify strength rather than put a hamper on growth.
Trading started low Friday, dropping 50 points in early morning only to rebound led by financials and pharmaceuticals. Pfizer saw a 1.4 percent increase for the morning, likely the result of United Therapeutics retracting an application to market a blood pressure medication overseas. Before noon the Dow Jones regained 38 of the points lost, falling only 0.1 percent to 10380.
The Nasdaq Composite was slipped slightly, dropping 0.2 percent while the Standard & Poor's 500 endured minor losses of 0.1 percent.
The fast recovery in financials, led by Bank of America gave many investors increased faith that financial institutions and the nation on the whole can continue to recovery without Federal supports.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a free one-year subscription
